Medicare beneficiaries with myeloma who also had outpatient prescription drug coverage had higher rates of active myeloma care compared with Medicare beneficiaries without a Medicare Part D plan, new research suggests.
Express Scripts is currently working with three pharmaceutical companies on plans to have its specialty pharmaceutical business exclusively distribute new hemophilia therapies once they become available in 2019 and 2020, Chief Medical Officer Steve Miller told Reuters.
Long-term use of azithromycin (Zithromax, Zmax) is associated with an increased risk of relapse in patients with cancer affecting the blood and lymph nodes, according to the FDA.
Express Scripts has announced new formulary exclusions including 48 drugs that will no longer be covered beginning in 2019.
Some drugs approved through the FDA's Breakthrough Therapy program have often been sent to patients without a double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis.
Changing the criminal penalties for drug possession could reduce racial and ethnic disparities in the criminal justice system and indirectly reduce health disparities as well, researchers suggest.
In the escalating battle over prescription drug prices, major pharmaceutical companies are trying to limit the economic damage from a new insurer tactic that steers patients away from expensive drugs.
The Trump administration has named a top White House lawyer as the new head of the DEA after the agency's prior acting administrator announced his retirement last month.
According to a recent settlement agreement, Pfizer will pay the government nearly $24 million to resolve allegations that it funneled money through a foundation resulting in illegal kickbacks.
In this Payer Roundtable, an expert panel discussed practices that can help even the playing field and ensure that your PBM partner is creating maximum value.